GSK’s 2016 Annual Report and Responsible Business Supplement

GSK’s 2016 Annual Report and Responsible Business Supplement

GSK is a science-led global healthcare company. Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. By growing our business and extending access to our medicines, we are ensuring long-term commercial success as well as improving people’s health, creating value for our shareholders and delivering economic benefits to society.

Review our 2016 Annual Report and Responsible Business Supplement

Learn more about GSK’s responsible business practices

Watch our new video series To Challenge. To Change.

Join the conversation on Twitter

Content from this campaign

External Recognition for Our Climate Change and Water Efforts
Our efforts to reduce carbon emissions were acknowledged in 2016 with our inclusion in the ‘Climate A List’. CDP assessed companies globally from across 10 industry sectors; we were one of only 193 companies (9% of applicants) and seven healthcare companies to be A-listed.  Our high rating reflects the significant steps we have taken to help meet our goal of becoming carbon neutral by...
Mar 31, 2017 10:00 AM ET
Investing in Sustainable Buildings
Our new building in Ware, UK, needs carefully controlled ambient temperature and humidity to store pharmaceutical samples. The building design makes it resilient against outdoor temperature changes, while minimising environmental impacts. The 200m2 of solar panels on the roof generate twice as much energy as the building needs, feeding the rest back into the grid. Inside, the rooms have...
Mar 29, 2017 9:00 AM ET
Building the Next Generation of Leaders
The programme was launched in 2012 to ensure a consistent, high-quality approach to our global graduate recruitment and development. The three-year programme consolidated and replaced several existing schemes with varied approaches. It provides a breadth of potentialcareer pathways – from R&D and finance, to marketing and procurement – with the option to move between functions during...
Mar 27, 2017 9:00 AM ET
Harnessing Online Networks to Improve Patient Care
Our pharmacovigilance centre of excellence collects publically available data from social media and filters out unrelated information and anything that would infringe patient privacy. The Centre’s analysis is helping us to understand the benefits of our products, alert us to unexpected adverse effects, and evaluate the misuse of drugs. In a two-year period, we found approximately 22...
Mar 24, 2017 9:00 AM ET
Access to Medicines Index
In 2016, we topped the Access to Medicine Index for the fifth consecutive time since it began in 2008. The index is an independent measure of the top 20 pharmaceutical companies’ efforts to improve access to healthcare in developing countries. Described as “the most access-oriented company”, GSK is recognized for a clear strategy on increasing access to medicines that aligns with its...
Mar 23, 2017 10:00 AM ET